1. Home
  2. RZLV vs ABVX Comparison

RZLV vs ABVX Comparison

Compare RZLV & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLV
  • ABVX
  • Stock Information
  • Founded
  • RZLV 2016
  • ABVX 2013
  • Country
  • RZLV United Kingdom
  • ABVX France
  • Employees
  • RZLV N/A
  • ABVX N/A
  • Industry
  • RZLV
  • ABVX
  • Sector
  • RZLV
  • ABVX
  • Exchange
  • RZLV NYSE
  • ABVX Nasdaq
  • Market Cap
  • RZLV 514.1M
  • ABVX 511.3M
  • IPO Year
  • RZLV N/A
  • ABVX N/A
  • Fundamental
  • Price
  • RZLV $1.92
  • ABVX $5.97
  • Analyst Decision
  • RZLV Strong Buy
  • ABVX Buy
  • Analyst Count
  • RZLV 5
  • ABVX 4
  • Target Price
  • RZLV $5.20
  • ABVX $31.50
  • AVG Volume (30 Days)
  • RZLV 3.5M
  • ABVX 320.0K
  • Earning Date
  • RZLV 02-21-2025
  • ABVX 03-24-2025
  • Dividend Yield
  • RZLV N/A
  • ABVX N/A
  • EPS Growth
  • RZLV N/A
  • ABVX N/A
  • EPS
  • RZLV N/A
  • ABVX N/A
  • Revenue
  • RZLV $187,788.00
  • ABVX $11,444,012.00
  • Revenue This Year
  • RZLV $18,916.66
  • ABVX $284.20
  • Revenue Next Year
  • RZLV $175.14
  • ABVX N/A
  • P/E Ratio
  • RZLV N/A
  • ABVX N/A
  • Revenue Growth
  • RZLV 29.46
  • ABVX 128.98
  • 52 Week Low
  • RZLV $1.07
  • ABVX $4.77
  • 52 Week High
  • RZLV $12.29
  • ABVX $14.22
  • Technical
  • Relative Strength Index (RSI)
  • RZLV N/A
  • ABVX 38.44
  • Support Level
  • RZLV N/A
  • ABVX $5.75
  • Resistance Level
  • RZLV N/A
  • ABVX $8.57
  • Average True Range (ATR)
  • RZLV 0.00
  • ABVX 0.55
  • MACD
  • RZLV 0.00
  • ABVX -0.17
  • Stochastic Oscillator
  • RZLV 0.00
  • ABVX 7.69

About RZLV REZOLVE AI LTD

Rezolve AI PLC is an AI-powered solutions company, specializing in enhancing customer engagement, operational efficiency, and revenue growth for the retail and e-commerce sectors. The company's product, Brain Commerce, powered by its proprietary Large Language Model (LLM) brainpowa, transforms the online shopping experience. By surpassing traditional site search and product discovery tools, Brain Commerce improves conversion rates, increases average order value (AOV), and reduces cart abandonment. The company has one reportable segment, which is cloud-based services. Geographically, the company generates revenue from Canada, the United States, Mexico, Australia, the United Kingdom, and Japan, with the majority of revenue generated from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: